Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 3;63(4):ezad083.
doi: 10.1093/ejcts/ezad083.

Upper gastrointestinal bleeding in adults treated with veno-arterial extracorporeal membrane oxygenation: a cohort study

Affiliations

Upper gastrointestinal bleeding in adults treated with veno-arterial extracorporeal membrane oxygenation: a cohort study

Jules Stern et al. Eur J Cardiothorac Surg. .

Abstract

Objectives: Upper gastrointestinal bleeding (UGIB) is a common complication in adults treated with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for refractory cardiogenic shock or cardiac arrest. We aimed to determine risk factors, prevalence and outcomes associated with VA-ECMO-associated UGIB in adult patients.

Methods: We conducted a retrospective cohort study (2014-2022) on consecutive VA-ECMO patients in the medical and infectious disease intensive care unit of Bichat-Claude Bernard University Hospital, Paris, France. UGIB was defined as (i) an overt bleeding (haematemesis, melena, haematochezia) or (ii) acute anaemia associated with a lesion diagnosed on upper gastrointestinal endoscopy. VA-ECMO-associated UGIB was defined as an UGIB occurring during VA-ECMO, or up to 10 days after decannulation in patients weaned off extracorporeal membrane oxygenation (ECMO). Cause-specific models were used to identify factors associated with UGIB and death, respectively.

Results: Among the 455 patients included, 48 (10%) were diagnosed with UGIB after a median of 12 [7; 23] days following ECMO cannulation. Mortality occurred in 36 (75%) patients with UGIB and 243 (60%) patients without. UGIB patients had longer intensive care unit stays (32 [19; 60] vs 18 [7; 37] days; P < 0.01), longer ECMO (14 [9; 18] vs 7 [4; 11] days; P < 0.01) and mechanical ventilation durations (21 [16; 36] vs 10 [5; 20] days; P < 0.01), as compared to non-UGIB patients. Ninety upper gastrointestinal endoscopies were performed, and the most frequent lesions detected were gastro-duodenal ulcers (n = 23, 26%), leading to 11/90 therapeutic procedures. By multivariable analysis, a history of peptic ulcer [cause-specific hazard ratio (CSHR) 2.93, 95% confidence interval (CI) [1.01; 8.51]], a dual antiplatelet therapy (CSHR 2.0, 95% CI [1.07; 3.72]) and extracorporeal cardiopulmonary resuscitation (CSHR 2.78, 95% CI [1.42; 5.45]) were independently associated with an increased risk of UGIB.

Conclusions: In adult patients under VA-ECMO, a history of gastric ulcer, dual antiplatelet therapy and extracorporeal cardiopulmonary resuscitation were independently associated with an increased risk of UGIB. This study highlights the potential role of acute ischaemia-reperfusion injury in the pathophysiology of VA-ECMO-associated UGIB.

Keywords: Endoscopy; Extracorporeal membrane oxygenation; Gastrointestinal haemorrhage; Intensive care units; Shock; cardiogenic; gastrointestinal.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Characteristics of upper gastrointestinal endoscopy (UGE). Risk factors for upper gastrointestinal bleeding, cause-specific multivariable analysis. Results are presented as hazard ratio [95% confidence interval]. Acute renal failure was defined as a renal Sepsis-related Organ Failure Assessment score >2.
None

Comment in

References

    1. Makdisi G, Wang IW.. Extra corporeal membrane oxygenation (ECMO) review of a lifesaving technology. J Thorac Dis 2015;7:E166–76. - PMC - PubMed
    1. Karagiannidis C, Brodie D, Strassmann S, Stoelben E, Philipp A, Bein T. et al. Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med 2016;42:889–96. - PubMed
    1. Mao J, Paul S, Sedrakyan A.. The evolving use of ECMO: the impact of the CESAR trial. Int J Surg 2016;35:95–9. - PubMed
    1. Liolios A, Oropello JM, Benjamin E.. Gastrointestinal complications in the intensive care unit. Clin Chest Med 1999;20:329–45, viii. - PubMed
    1. Plummer MP, Blaser AR, Deane AM.. Stress ulceration: prevalence, pathology and association with adverse outcomes. Crit Care 2014;18:213. - PMC - PubMed

Substances